Polymeric Nanoparticle-Mediated Delivery of Oncolytic Measles Virus for Targeted Therapy in Cervical Cancer. Pharmaceutical Communications, [S. l.], v. 3, n. 1, p. 45–53, 2024. DOI: 10.55627/pharma.003.001.0887. Disponível em: https://rootspress.org/journals/pharma/article/view/887. Acesso em: 23 apr. 2026.